Stanford Advisors


All Publications


  • iPSC model of congenital heart disease predicts disease outcome. Cell stem cell Tripathi, D., Reddy, S. 2022; 29 (5): 659-660

    Abstract

    In this issue of Cell Stem Cell, Xu etal. demonstrate that induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome exhibit mitochondrial dysfunction and can be used for disease modeling. In addition, they show the potential to predict future heart failure and develop therapies.

    View details for DOI 10.1016/j.stem.2022.04.010

    View details for PubMedID 35523134